Results · Apr-Jun 2026 · filed 3 Aug 2026
Artemis Medicare Services Q1 FY27 results
StrongStrong: sales up 10% or more & profit up 20% or more on the same quarter last year, with a wider operating margin.
Sales grew 13% to ₹287 crore from ₹255 crore in Apr-Jun 2025.
Operating profit grew 36% to ₹56.4 crore, an operating margin of 19.6% (up 3.4 points from a year ago).
Net profit grew 48% to ₹31.4 crore from ₹21.2 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +3%, net profit +4%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 287.3 | 255.0 | +13% |
| Operating profit (EBITDA) | 56.4 | 41.4 | +36% |
| Operating margin | 19.6% | 16.2% | +3.4 pts |
| Net profit | 31.4 | 21.2 | +48% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 4 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 4 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 3 Aug 2026Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- 3 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 3 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 3 Aug 2026Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- 3 Aug 2026Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026
- 3 Aug 2026Board Meeting Outcome for Board Meeting Held On August 3, 2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.